Figure S2 from Randomized Phase 0/I Trial of the Mitochondrial Inhibitor ME-344 or Placebo Added to Bevacizumab in Early HER2-Negative Breast Cancer
openalex(2023)
Key words
Tumor Microenvironment,tumor,Cancer,Metastatic Breast Cancer,Cancer Cell Metabolism
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined